首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Cancer science

缩写:CANCER SCI

ISSN:1347-9032

e-ISSN:1349-7006

IF/分区:4.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引6291条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Keita H Nagaoka,Hiroki Yamashita,Chiaki Mashima et al. Keita H Nagaoka et al.
The tumor microenvironment (TME) in gastric cancer (GC) is a dynamic ecosystem where immune, stromal, and malignant cells influence therapeutic outcomes. Although macrophages and neutrophils are key regulators of the TME, their coordinated ...
Momoko Tokura,Jun Nakayama,Hironori Suzuki et al. Momoko Tokura et al.
Invasive lobular carcinoma (ILC) is a special type of breast cancer. The histological subtypes of ILC exhibit diverse morphological features, and the prognosis differs accordingly. Compared with patients with classic-ILC (C-ILC), patients w...
Bhoomi Shah,Mackenzie M Mayhew,Jacob Sellers et al. Bhoomi Shah et al.
Though major advancements have been made within the realm of targeted and immune-based therapies, metastatic melanoma still remains one of the most notoriously incurable malignancies due to early drug tolerance and eventual resistance. Incr...
Xinwei Zhou,Zheng Zhao,Ning Sun et al. Xinwei Zhou et al.
Pancreatic adenocarcinoma (PAAD) is a highly aggressive malignancy characterized by rapid progression. In this study, we identify the small MAF protein, MAFF, as a critical driver of PAAD tumorigenesis and a negative regulator of the necrop...
Fei Zhao,Wenhao Wang,Hongye Gao et al. Fei Zhao et al.
Relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the leading cause of treatment failure in acute myeloid leukemia (AML), yet the non-coding RNA-mediated regulatory mechanisms in relapse-driving tumor clon...
Junichi Shimizu,Makoto Nishio,Kadoaki Ohashi et al. Junichi Shimizu et al.
Pivotal phase 3 trials leading to the approvals of atezolizumab─chemotherapy combinations for non-small cell and extensive-stage small cell lung cancer (NSCLC and ES-SCLC) had strict eligibility criteria. J-TAIL-2 was a prospective, observ...
Wenjie Yang,Zhaoheng Jin,Ziyi Li et al. Wenjie Yang et al.
Lysine acetyltransferase 2A (KAT2A) is a transcriptional coactivator and a member of the Histone Acetyltransferase (HAT) family. While altered KAT2A activity has been implicated in various cancers, its role in bladder cancer (BLCA) remains ...
Xu Wang,Cuiwei Liu,Zihan Xia et al. Xu Wang et al.
Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with limited therapeutic options. Radiotherapy (RT) is a cornerstone of TNBC treatment; however, preclinical studies suggest that RT may both stimulate an...
Akinari Sugauchi,Toshihiro Uchihashi,Hirotaka Ito et al. Akinari Sugauchi et al.
Cervical lymph node metastasis is a major predictor of poor prognosis in patients with oral squamous cell carcinoma (OSCC), underscoring the need for therapies that effectively target metastatic spread. We previously reported that G47Δ, a ...
Yoshimi Yasukawa,Naoko Hattori,Yu-Yu Liu et al. Yoshimi Yasukawa et al.
Scirrhous gastric cancer has aggressive clinical courses and is characterized by dominating cancer-associated fibroblasts (CAFs). However, the origin of scirrhous CAFs remains unclear, and we here aimed to explore the epigenetic basis for s...